Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
| Country | United States |
|---|---|
| Deadline | 2027-07-02 (222 days left) |
| Published | 2024-12-06 |
| Sectors | Health & life sciences |
| Source | Grants.gov (US) |
Summary
Funding opportunity RFA-TR-25-002. CFDA: 93.350
The buyer, the value, the full description and the link to the official notice are available with a free account.